InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
T+90 hit rate
31%
T+90 mean return
-10.3%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Brown Michael J, Director. Insider active across 5 companies, notably Monopar Therapeutics. In total, 43 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €14.7m. Activity tracked since 11 June 2021. The latest transaction was filed on 13 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations43 total
95,000 shares@ US$100.6934.9% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-25-024528:0
38,985 shares0Common Stock, par value $0.02 per shareSEC:0001213900-25-018234:0
67,122 shares@ US$56.2414.3% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-24-107042:0
12,395 shares0Common Stock, par value $0.02 per shareSEC:0001213900-24-017109:0
2,533 sharesCommon StockSEC:0001437749-24-000487:0
59,324 shares@ US$45.939.9% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-23-093189:0
8,500 shares@ US$45.931.5% of flowCommon Stock, par value $0.02 per shareSEC:0001013762-23-004099:0
2,533 sharesCommon StockSEC:0001437749-23-027584:0
2,000 shares@ US$79.001.5% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-23-079928:0
2,534 sharesCommon StockSEC:0001437749-23-019261:0
43,443 shares@ US$120.6119.2% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-23-042630:0
2,533 sharesCommon StockSEC:0001437749-23-009335:0
988 shares@ US$107.560.4% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-23-014432:0
2,000 shares@ US$115.450.8% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-23-007397:0
2,859 sharesCommon StockSEC:0001437749-23-000172:0
220 shares@ US$93.370.1% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-22-083459:0
2,000 shares@ US$92.370.7% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-22-079829:0
76,844 shares@ US$23.637.0% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-22-077150:0
25,000 shares@ US$23.632.3% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-22-074641:0
2,859 sharesCommon StockSEC:0001654954-22-013277:0
2,859 sharesCommon StockSEC:0001654954-22-009146:0
1,486 shares0Common stock, par value $0.01SEC:0001209191-22-036780:0
10,000 shares@ US$111.110.036% mcap33.8% of flowCommon Stock, par value $0.02 per shareSEC:0001213900-22-027240:0
2,859 sharesCommon StockSEC:0001654954-22-004478:0
5,629 shares0Common Stock, par value $0.02 per shareSEC:0001213900-22-009211:0
25 of 43 declarations
About Brown Michael J
Michael J Brown is an executive at Monopar Therapeutics.
